FDA Approves Vaccine for Prevention of Smallpox, Monkeypox

WEDNESDAY, Sept. 25, 2019 — Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, was approved by the U.S. Food and Drug Administration for prevention of smallpox and monkeypox disease in adults 18 years or older who are considered at high…
Source: Topamax